Researchers recently conducted a comprehensive review of recently published literature to estimate anti-hepatitis C virus (HCV) prevalence, the viraemic rate (HCV-RNA positive), and genotype distribution in order to create a global estimate of hepatitis C disease burden.
The systematic study published in the World Journal of Gastroenterology is representative of one of the most comprehensive efforts to quantify global HCV epidemiology. Recent estimates have shown an increase in HCV seroprevalence over the last decade to 2.8%, which equates to 185 million infections globally.
For the study, a comprehensive review of literature from 2000 to 2015 was conducted in order to gather country-specific prevalence. The regions included in the analysis were defined by the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD) study.